SCHEMBL7734014

SCHEMBL7734014

CC(C)(C)OC(=O)N1C[C@H](N(C(=O)CN)C(=O)OC(C)(C)C)C[C@H]1C(=O)N1CCN(c2ccc(F)cc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 1/20 0.39
TGM2 P21980 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
GPR119 Q8TDV5 1/20 0.36
MMP2 P08253 1/20 0.36
MMP13 P45452 1/20 0.36
MMP14 P50281 1/20 0.36
ADAMTS5 Q9UNA0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7730697 0.91 SMN1; SMN2 (0.44) GAAALDH1A1MEN1KMT2AHTT
SCHEMBL7728745 0.86 MAPT (0.44) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL7722004 0.84 TGM2 (0.40) GAAMEN1KMT2ATGM2LMNA
SCHEMBL7727837 0.78 SIGMAR1 (0.43)
SCHEMBL7728662 0.76 DPP4 (0.42) MEN1KMT2ATGM2
SCHEMBL7728185 0.76 HSD17B10 (0.34) CYP1A2CYP3A4CYP2C19
SCHEMBL7726101 0.76 HSD17B10 (0.34) CYP1A2CYP3A4CYP2C19
SCHEMBL7727961 0.76 HSD17B10 (0.34) CYP1A2CYP3A4CYP2C19
SCHEMBL7722094 0.76 GPR119 (0.36) GPR119
SCHEMBL7722244 0.76 GPR119 (0.36) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed